Valneva SE
SWB:AYJ
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Valneva SE
SWB:AYJ
|
FR |
|
C
|
Copart Inc
F:CO6
|
US |
|
L
|
Lundin Gold Inc
STO:LUG
|
CA |
|
Cingulate Inc
NASDAQ:CING
|
US |
|
A
|
Anheuser-Busch Inbev SA
F:ITKA
|
BE |
|
GTN Industries Ltd
BSE:500170
|
IN |
|
R
|
Rajapalayam Mills Ltd
BSE:532503
|
IN |
Intrinsic Value
Is AYJ undervalued or overvalued?
See the intrinsic value estimate for 
Valneva SE and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Valneva Does
Valneva is a vaccine company. It develops, makes, and sells vaccines that help prevent infectious diseases, with a focus on travel and other niche areas where public health agencies and doctors need specific protection rather than broad everyday medicines. Its best-known products include vaccines for diseases such as Japanese encephalitis, cholera, and other travel-related infections, along with vaccine candidates still in development.
- Headquarters
- France FR
- Employees
- 674
- IPO date
- Jun 28, 2007
Revenue & Expenses Breakdown
Valneva SE
Earnings Waterfall
Valneva SE
The intrinsic value for Valneva SE (AYJ) under the Base Case is hidden EUR.
Compared with the current market price of 2.383 EUR, the stock appears hidden.